PBS updates

Dysport (clostridium botulinum type A toxin-haemagglutinin complex)

clostridium botulinum type A toxin-haemagglutinin complex 300 units injection, 1 vial · INJECTION · PBS code 11831Q

STREAMLINED

What it costs

AU$228.39 PBS-determined price per 5 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2019-12-01.
  • • Repeats: 0.
  • • PBS program: MF.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Moderate to severe spasticity of the lower limb following an acute event


Must be treated by a neurologist; or

Must be treated by an orthopaedic surgeon; or

Must be treated by a rehabilitation specialist; or

Must be treated by a plastic surgeon; or

Must be treated by a geriatrician; AND

The condition must be moderate to severe spasticity of the lower limb/s following stroke or other acute neurological event, defined as a Modified Ashworth Scale rating of 3 or more; AND

The treatment must only be used as second line therapy when standard management has failed; or

The treatment must only be used as an adjunct to physical therapy; AND

The treatment must not continue if the patient does not respond (defined as not having had a decrease in spasticity rating of at least 1, using the Modified Ashworth Scale, in at least one joint) after two treatment periods (with any botulinum toxin type A); AND

Patient must not have established severe contracture in the limb to be treated; AND

The treatment must not exceed a maximum of 4 treatment periods (with any botulinum toxin type A) per lower limb in the the first year of treatment, and 2 treatment periods (with any botulinum toxin type A) per lower limb each year thereafter; AND

Patient must be aged 18 years or older.

Standard management includes physiotherapy and/or oral spasticity agents.

Sponsor: Ipsen Pty Ltd ABN 47 095 036 909

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.